← Back to headlines
Immunic Receives New 'Buy' Rating from Guggenheim on Lead Asset
Immunic has garnered a new 'Buy' rating from Guggenheim, indicating positive analyst sentiment regarding its lead asset.
24 Mar, 15:48 — 24 Mar, 15:48
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
PNP intensifies crackdown on illegal cigarette trade after P799M Negros bust
just now
Five Arrested in Bataan for Tampered LPG Cylinders
just now
Manila Archdiocese Calls for Used Cooking Oil Collection for Biodiesel Amid Fuel Crisis
just now